Obesity has recently been found to be favorable for the response to immune checkpoint inhibitors in different tumors [156] so cytokine homeostasis, and more specifically, leptin homeostasis, could also be an important factor considered as both the modulated and modulator of the future efficacy of therapies in cancer. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.